CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
What drives stock market index performance includes macro trends, earnings, and valuation shifts. This overview explains the main forces behind movements.
27,569 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Investors are weighing a bold 2028 target for McDonald’s as loyalty growth and margin leverage could lift the stock, ...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
Ark Invest's July activity shows notable interest in Kratos Defense. This article breaks down what the buys mean, the...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...
A landmark agreement between Apple and Broadcom signals a major shift in chip strategy and domestic manufacturing. Th...
A veteran investor recounts how being wrong about inflation missed a powerful stock rally and details a straightforwa...
A top executive recently moved a sizable block of Impinj stock. This article unpacks why insider sales happen, how to...
Markets edge higher as Tuesday’s best Wall Street analyst calls spotlight Adobe, Meta, and other names across tech, e...
Amazon’s hidden silicon engine is lifting cloud profits, with Trainium, Graviton, and Nitro driving a new growth wave...
Teads released its Q1 2026 results, showing resilience in a volatile ad market. This investor-focused guide breaks do...
SpaceX is signaling a public debut that could rewrite IPO benchmarks, even as critics warn the proposed governance st...